2026-02-05 北海道大学
<関連情報>
- https://www.hokudai.ac.jp/news/2026/02/17700.html
- https://www.hokudai.ac.jp/news/pdf/260205_pr.pdf
- https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843525
日本におけるパンデミック期の規制緩和中及び規制緩和後の遠隔医療の利用実態 Telemedicine Uptake During and After Pandemic-Era Deregulation in Japan
Kazuki Ohashi, PhD; Kazuhiro Abe, PhD; Yoko Shizawa, MPH;et al
JAMA Network Open Published:January 9, 2026
DOI:10.1001/jamanetworkopen.2025.53150
Introduction
The COVID-19 pandemic accelerated telemedicine use worldwide. In 2022, 39.3% of US adults reported using telemedicine at least once in the previous 12 months.1 In Japan, telemedicine was expanded to initial and follow-up visits under COVID-19–related deregulation starting in April 2020. An internet-based survey by Miyawaki et al2 found that only 4.7% of adults aged 18 to 79 years used telemedicine early in this deregulation. The deregulation ended on August 1, 2023, after which telemedicine was required to be video-based care at preregistered facilities.3 Although Japan’s telemedicine environment changed markedly after the pandemic, its post-COVID-19 period use and age-specific changes before and after the deregulation remain unclear. Evidence from claims data rather than self-reports has been lacking. This study describes telemedicine use across all ages using claims data covering the deregulation and postderegulation periods.
